Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	5-hydroxytryptamine receptor 6
Species	Homo sapiens (Human)
Gene	HTR6
Synonym	5-HT6 receptor 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled 5-HT-6 serotonin receptor 6 ST-B17 5-HT6 [ Show all ]
Disease	Schizophrenia Obesity Neurological disease Neurodegenerative disease Emesis Cognitive disorders Unspecified Anxiety disorder Alzheimer disease; Dementia Alzheimer disease; Anxiety disorder Alzheimer disease [ Show all ]
Length	440
Amino acid sequence	MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
UniProt	P50406
Protein Data Bank	N/A
GPCR-HGmod model	P50406
3D structure model	This predicted structure model is from GPCR-EXP P50406.
BioLiP	N/A
Therapeutic Target Database	T16691
ChEMBL	CHEMBL3371
IUPHAR	11
DrugBank	BE0000945

Ligand

Name	quipazine
Molecular formula	C13H15N3
IUPAC name	2-piperazin-1-ylquinoline
Molecular weight	213.284
Hydrogen bond acceptor	3
Hydrogen bond donor	1
XlogP	1.5
Synonyms	2-Piperazin-1-ylquinoline Prestwick2_000617 AB00053761 Quipazine [INN] AC1Q1I54 SPBio_001223 AS-38262 TC-071714 BRD-K77925998-332-03-8 CHEMBL18772 GTPL173 KBioGR_001818 MCULE-2654170894 2-(1-piperazinyl)-quinoline NCGC00024694-02 Oprea1_342540 4WCY05C0SJ Quinoline, 2-(1-piperazinyl)- AB00053761_12 RP26765 AK-26012 Spectrum3_001824 Biomol-NT_000103 UNII-4WCY05C0SJ BSPBio_003467 DB-021505 KBio1_000911 L000958 1-(2-Quinolyl)piperazine NCGC00015872-02 2-(piperazin-1-yl)-quinoline 2-Piperazin-1-yl-quinoline (Quipazine) Prestwick0_000617 5786-68-5 (maleate (1:1)) Quipazina [INN-Spanish] AC-22858 SBI-0050992.P003 AMOT0412 ST50232723 BRD-K77925998-001-01-3 XRXDAJYKGWNHTQ-UHFFFAOYSA-N CHEBI:93368 F3306-0004 KBio2_007349 LS-142110 NCGC00015872-06 NCGC00024694-03 2-quinolylpiperazine Prestwick3_000617 AB00053761-06 Quipazinum AC1Q4WAV SPBio_002773 BAS 00505227 Tocris-0629 BRN 0196945 CTK4J0220 IDI1_000911 KBioSS_002213 MolPort-000-006-267 2-(1-Piperazinyl)chinolin P67440 5-23-03-00069 (Beilstein Handbook Reference) Quinoline,2-(1-piperazinyl)- AB0076939 S14-1965 AKOS000124312 Spectrum4_001259 BPBio1_000610 VQ10136 CAS-4774-24-7 DivK1c_000911 KBio2_002213 Lopac-Q-1004 1-(quinolin-2-yl)piperazine NCGC00015872-03 2-(piperazin-1-yl)quinoline 2-Piperazin-1-yl-quinoline(Quipazine) Prestwick1_000617 774P247 AC1L1JEX SCHEMBL322181 ANW-66727 STL308727 BRD-K77925998-050-02-8 ZINC2020 FT-0635438 KBio3_002971 MA-1291 2-(1-PIPERAZINO)QUINOLINE NCGC00024694-01 NINDS_000911 4774-24-7 Q-103520 AB00053761_11 Quipazinum [INN-Latin] AJ-73031 Spectrum2_001182 BDBM50014407 TPC-A004 BSPBio_000554 D08BCF KB-25984 L-2584 1-(2-Quinolinyl)piperazine NCGC00015872-01 2-(1-Piperazinyl)quinoline 2-Piperazin-1-yl-quinoline piperazin-1-yl-quinoline Quipazina AB05466 SBB011283 AM20061242 Spectrum_001733 BPBio1_001393 VU0005330-3 CCG-205099 DTXSID3046952 KBio2_004781 Lopac0_001019 130895-61-3 NCGC00015872-04 [ Show all ]
Inchi Key	XRXDAJYKGWNHTQ-UHFFFAOYSA-N
Inchi ID	InChI=1S/C13H15N3/c1-2-4-12-11(3-1)5-6-13(15-12)16-9-7-14-8-10-16/h1-6,14H,7-10H2
PubChem CID	5011
ChEMBL	CHEMBL18772
IUPHAR	173
BindingDB	50014407
DrugBank	N/A
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
Ki	3600.0 nM	PMID8522988, PMID12825922	PDSP,BindingDB,ChEMBL

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417